Applied Therapeutics Inc buy BiotechBee
Start price
18.02.24
/
60%
€5.80
Target price
31.01.26
€4.00
Performance (%)
-31.03%
Price
24.04.24
€4.00
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Applied Therapeutics Inc is performing very badly with a performance of -31.03%. This prediction currently runs until 31.01.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Applied Therapeutics Inc | - | - |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
According to BiotechBee what are the pros and cons of Applied Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Applied Therapeutics Inc diskutieren
Stopped prediction by BiotechBee for Applied Therapeutics Inc
Applied Therapeutics Inc
Start price
Target price
Perf. (%)
€2.67
24.12.23
24.12.23
€5.00
31.08.25
31.08.25
-16.32%
05.01.24
05.01.24
Could be very worthwhile Investment >20% year
Applied Therapeutics Inc
Start price
Target price
Perf. (%)
€2.75
10.12.23
10.12.23
€3.50
31.03.26
31.03.26
-3.09%
24.12.23
24.12.23
Could be very worthwhile Investment >20% year